Skip to main content

Share story

Products

The Trump Administration Launched an Official White House App

The Trump Administration Launched an Official White House App Image: Primary
The Trump administration has released an official White House app, available on the App Store and Google Play, claiming to offer Americans direct access to the administration's communications and announcements, Engadget reports. The app follows a pattern of the administration building its own media infrastructure and distribution channels, bypassing traditional press intermediaries. Engadget's review describes the app as unnecessary and unusual in its design and content. The launch raises questions that any official government app would: what data is collected, how it is used, and whether it functions primarily as a communication tool or a political branding platform. The app's existence also comes amid broader scrutiny of the administration's relationship with technology platforms and its approach to digital communication.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Engadget and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.